TABLE 2.
Treatment | No. of specimens positive for HIV by NASBA/no. tested (no. Cx positive/no. tested)
|
Mean viral load ± SE (range) in:
|
No. with toxic lesions/no. tested | ||
---|---|---|---|---|---|
Spleen | PL | Spleen | PL | ||
i.p. route | |||||
Control (vehicle) (n = 16) | 15/16 (16/16) | 14/14 | 4.5 ± 0.2 (3.2-5.5) | 4.6 ± 0.2 (3.3-5.9) | 0/10 |
STAMP dose (mg/kg) | |||||
10 (n = 10) | 4/5 (4/5) | 2/10 | 3.9 ± 0.3 (3.1-4.3) | 3.8 ± 0.3 (2.9-4.3) | 0/5 |
25 (n = 5) | 2/5 (2/5) | 2/5 | 3.8 ± 0.6 (3.2-4.4) | 3.5 ± 0.7 (2.8-4.2) | 0/5 |
50 (n = 15) | 6/15 (4/15) | 1/15 | 4.2 ± 0.1 (4.0-4.7) | 4.1 | 0/15 |
100 (n = 9) | 2/8 (0/7) | 0/9 | 3.5 ± 0.3 (3.3-3.8) | NAb | 0/9 |
Gavage | |||||
Control (vehicle) (n = 23) | 20/22 | 23/23 | 4.4 ± 0.1 (3.3-5.6) | 5.9 ± 0.2 (4.2-7.2) | 0/16 |
STAMP dose (mg/kg) | |||||
50 (n = 10) | 4/10 | 7/10 | 4.4 ± 0.3 (3.8-5.3) | 5.0 ± 0.3 (3.8-5.7) | NDc |
100 (n = 20) | 7/20 | 12/20 | 4.0 ± 0.3 (3.1-5.1) | 4.8 ± 0.3 (3.1-6.2) | 0/10 |
200 (n = 20) | 7/20 | 12/20 | 3.7 ± 0.2 (3.2-4.5) | 4.8 ± 0.2 (3.2-5.9) | 0/9 |
400 (n = 9) | 0/9 | 1/9 | NA | 4.8 | 0/9 |
Combivir (n = 10)d | 3/10 | 6/10 | 3.2 ± 0.3 (1.5-3.4) | 4.0 ± 0.4 (3.0-5.2) | ND |
Added to food | |||||
Control (vehicle) (n = 20) | 15/20 | 17/20 | 4.4 ± 0.2 (3.0-6.4) | 4.3 ± 0.2 (2.9-5.5) | 0/10 |
STAMP dose (mg/kg) | |||||
200 (n = 10) | 3/10 | 5/8 | 3.8 ± 0.5 (3.2-4.8) | 4.3 ± 0.3 (3.4-5.1) | 0/10 |
400 (n = 10) | 1/10 | 1/9 | 3.0 | 3.1 | 0/10 |
Drugs were administered i.p. or via gavage twice daily for 7 days/week for 2 weeks. All mice were reconstituted with 107 PBMC and infected with 105 50% tissue culture infective dose of the HIV-1 isolate BR/92/019 2 weeks after reconstitution. Treatments were started immediately after the inoculation of the HIV-1 isolate. Results are presented as the fractions of HIV-NASBA positive and HIV coculture-positive mice as well as the arithmetic mean values of the log10-transformed spleen and peritoneal lavage (PL) viral loads with (ranges are indicated in parentheses). The median values and geometric means for the log10-transformed spleen (peritoneal lavage) viral loads in i.p.-treated mice were, respectively, 4.5 and 4.4 (4.6 and 4.5) for vehicle controls, 4.1 and 3.9 (4.1 and 3.8) for 10-mg/kg STAMP, 3.8 and 3.8 (3.5 and 3.4) for 25-mg/kg STAMP, 4.0 and 4.0 for 50-mg/kg STAMP, and 3.6 and 3.5 for 100-mg/kg STAMP. The median values and geometric means for the log10-transformed spleen (peritoneal lavage) viral loads in gavage-treated mice were, respectively, 4.5 and 4.4 (6.0 and 5.9) for vehicle controls, 4.4 and 4.4 (5.3 and 5.0) for 50-mg/kg STAMP, 3.9 and 3.9 (5.0 and 4.7) for 100-mg/kg STAMP, and 3.7 and 3.7 (4.9 and 4.8) for 200-mg/kg STAMP. The median values and geometric means for the log10 transformed spleen (peritoneal lavage) viral loads in p.o. (food supplement)-treated mice were, respectively, 4.0 and 4.3 (4.5 and 4.3) for vehicle controls and 3.5 and 3.8 (4.6 and 4.3) for 200-mg/kg STAMP.
NA, not applicable.
ND, not determined.
Combivir is 400-mg/kg ZDV plus 200-mg/kg 3TC.